Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol or its prodrug in the treatment of behavioral or psychological symptoms associated with a disease

Use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol or its prodrug in the treatment of behavioral or psychological symptoms associated with a disease

US Patent 7132433 · Granted Nov 7, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemet2005
Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemet2005
Use of R(+) -&agr;-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idi2003
Use of R(+) -&agr;-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idi2003
Use of R- +)-.alpha.-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperid2001
Use of R- +)-.alpha.-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperid2001
Xanthine derivatives as adenosine A1 receptor antagonists1998
Xanthine derivatives as adenosine A1 receptor antagonists1998
5-aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerati1995
Use of 1,4-disubstituted-piperidinyl compounds for analgesia and muscle relaxati1992
1,4-disubstituted-piperidinyl compounds as pain relievers1991
Medicament compositions derived from quinolizine and quinolizinone and methods o1991